Document detail
ID

oai:pubmedcentral.nih.gov:1023...

Topic
Research
Author
Oware, Kevin Adiema, Lydia Rono, Bernard Violette, Lauren R. McClelland, R. Scott Donnell, Deborah Scoville, Caitlin W. Odoyo, Josephine Baeten, Jared M. Bukusi, Elizabeth Stewart, Jenell
Langue
en
Editor

BioMed Central

Category

BMC Women's Health

Year

2023

listing date

12/12/2023

Keywords
incidence curable characteristics sti doxycycline hiv prophylaxis sex stis trial
Metrics

Abstract

INTRODUCTION: The global incidence of sexually transmitted infections (STIs) has been rapidly increasing over the past decade, with more than one million curable STIs being acquired daily.

Young women in sub-Saharan Africa have a high prevalence and incidence of both curable STIs and HIV.

The use of doxycycline as a prophylaxis to prevent STIs is promising; however, clinical trials, to date, have only been conducted among men who have sex with men (MSM) in high-income settings.

We describe the characteristics of participants enrolled in the first trial to determine the efficacy of doxycycline post-exposure prophylaxis (PEP) to reduce STI incidence among women taking daily, oral HIV pre-exposure prophylaxis (PrEP).

METHODS: This is an open-label 1:1 randomized clinical trial on the efficacy of doxycycline PEP compared with standard of care (e.g., quarterly STI screening and treatment) to reduce incident bacterial STIs – Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum – among Kenyan women aged ≥18 and ≤30 years.

All were also taking HIV pre-exposure prophylaxis (PrEP).

We describe the baseline characteristics, STI prevalence, and STI risk perception of participants.

RESULTS: Between February 2020 and November 2021, 449 women were enrolled.

The median age was 24 years (IQR 21–27), the majority were never married (66.1%), 370 women (82.4%) reported having a primary sex partner, and 33% had sex with new partners in the three months prior to enrolment.

Two-thirds (67.5%, 268 women) did not use condoms, 36.7% reported transactional sex, and 43.2% suspected their male partners of having sex with other women.

Slightly less than half (45.9%, 206 women) were recently concerned about being exposed to an STI.

The prevalence of STIs was 17.9%, with C. trachomatis accounting for the majority of infections.

Perceived risk of STIs was not associated with the detection of an STI.

CONCLUSION: Young cisgender women using HIV PrEP in Kenya and enrolled in a trial of doxycycline postexposure prophylaxis had a high prevalence of curable STIs and represent a target population for an STI prevention intervention.

Oware, Kevin,Adiema, Lydia,Rono, Bernard,Violette, Lauren R.,McClelland, R. Scott,Donnell, Deborah,Scoville, Caitlin W.,Odoyo, Josephine,Baeten, Jared M.,Bukusi, Elizabeth,Stewart, Jenell, 2023, Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention, BioMed Central

Document

Open Open

Share

Source

Articles recommended by ES/IODE AI

Lung cancer risk and exposure to air pollution: a multicenter North China case–control study involving 14604 subjects
lung cancer case–control air pollution never-smokers nomogram model controls lung-related 14604 subjects north polluted consistent smokers quit exposure lung cancer risk air people factor smoking pollution study history